Stemtech (STEK) Accumulated Expenses (2012 - 2021)

Stemtech has disclosed Accumulated Expenses across 10 years of filings, most recently posting $23000.0 for Q4 2021.

• Accumulated Expenses for Q4 2021 came in at $23000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $23000.0 (changed N/A YoY), and the FY2021 annual result was $23000.0, up 9.52% from the prior year.
• Accumulated Expenses came in at $23000.0 for Q4 2021 at Stemtech, down from $402137.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $402137.0 in Q3 2021 to a low of $20370.0 in Q1 2017.
• The 5-year median for Accumulated Expenses is $42031.5 (2018), against an average of $62579.0.
• Peak annual rise in Accumulated Expenses reached 103.94% in 2017, while the deepest fall reached 3.71% in 2017.
• Stemtech's Accumulated Expenses stood at $36071.0 in 2017, then gained by 20.52% to $43473.0 in 2018, then jumped by 32.94% to $57795.0 in 2019, then advanced by 0.75% to $58228.0 in 2020, then plunged by 60.5% to $23000.0 in 2021.
• The last three Accumulated Expenses figures came in at $23000.0 (Q4 2021), $402137.0 (Q3 2021), and $58228.0 (Q2 2020), per Business Quant data.